Dr Andrew Sanders

2023

• Ye, L., Sanders, A. J. and Jiang, W. G. 2023. Transglutaminase-4 (prostate transglutaminase), a potential biological factor and clinical indicator for the diagnosis and prognosis of prostate cancer. Anticancer Research 43(1), pp. 291-296. (10.21873/anticanres.16162)
• Li, A. X. et al. 2023. Striatins and the STRIPAK complex partners in the clinical outcome of patients with breast cancer and responses to drug treatment. Chinese Journal of Cancer Research 35, pp. 365-385. (10.21147/j.issn.1000-9604.2023.04.04)

2022

• Zeng, J., Sanders, A. J., Lin, Y., Hargest, R., Ruge, F. and Jiang, W. G. 2022. EPLIN, a putative tumour suppressor in colorectal cancer, implications in drug resistance. International Journal of Molecular Sciences 23(23), article number: 15232. (10.3390/ijms232315232)
• Cheng, X. et al. 2022. Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer. Cell Death and Disease 13(11), pp. 998. (10.1038/s41419-022-05453-w)
• Sui, L., Sanders, A., Jiang, W. G. and Ye, L. 2022. Deregulated molecules and pathways in the predisposition and dissemination of breast cancer cells to bone. Computational and Structural Biotechnology Journal 20, pp. 2745-2758. (10.1016/j.csbj.2022.05.051)
• Telford, E. A., Sanders, A. J., Owen, S., Ruge, F., Harrison, G. M., Jiang, W. G. and Martin, T. A. 2022. Hepatitis A virus cellular receptor 1 (HAVcr-1) initiates prostate cancer progression in human cells via hepatocyte growth factor (HGF)-induced changes in junctional integrity. Biomolecules 12(2), article number: 338. (10.3390/biom12020338)

2021

• Bosanquet, D. C. et al. 2021. Sensitivity of the wound edge gene signature "WD14" in responding to clinical change: a longitudinal cohort study. International Journal of Lower Extremity Wounds (10.1177/15347346211056786)
• Lin, Q. et al. 2021. Silencing CTNND1 mediates triple-negative breast cancer bone metastasis via upregulating CXCR4/CXCL12 axis and neutrophils infiltration in bone. Cancers 13(22), article number: 5703. (10.3390/cancers13225703)
• Yang, Y., Sanders, A. J., Dou, Q. P., Jiang, D. G., Li, A. X. and Jiang, W. G. 2021. The clinical and theranostic values of activated leukocyte cell adhesion molecule (ALCAM)/CD166 in human solid cancers. Cancers 13(20), article number: 5187. (10.3390/cancers13205187)
• Zeng, J., Jiang, W. G. and Sanders, A. J. 2021. Epithelial Protein Lost in Neoplasm, EPLIN, the cellular and molecular prospects in cancers. Biomolecules 11(7), article number: 1038. (10.3390/biom11071038)
• Sui, L., Ye, L., Sanders, A. J., Yang, Y., Hao, C., Hargest, R. and Jiang, W. G. 2021. Expression of death associated proteins DAP1 and DAP3 in human pancreatic cancer. Anticancer Research 41(5), pp. 2357-2362. (10.21873/anticanres.15010)
• Gong, W., Zeng, J., Ji, J., Jia, Y., Jia, S., Sanders, A. J. and Jiang, W. G. 2021. EPLIN expression in gastric cancer and impact on prognosis and chemoresistance. Biomolecules 11(4), article number: 547. (10.3390/biom11040547)
• Gong, W., Martin, T. A., Sanders, A. J., Jiang, A., Sun, P. and Jiang, W. G. 2021. Location, function and role of stromal cell-derived factors and possible implications in cancer. International Journal of Molecular Medicine 47(2), pp. 435-443. (10.3892/ijmm.2020.4811)

2020

• Cheng, X. et al. 2020. TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer. Cell Death and Disease 11, pp. -., article number: 92. (10.1038/s41419-020-2272-z)

2019

• Tan, W. et al. 2019. Incorporating MicroRNA into molecular phenotypes of circulating tumor cells enhances the prognostic accuracy for patients with metastatic breast cancer. Oncologist 24, pp. e1044-e1054. (10.1634/theoncologist.2018-0697)
• Sanders, A. et al. 2019. Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination. Oncotarget 10(59), pp. 6362-6377. (10.18632/oncotarget.27279)
• Bosanquet, D. C., Sanders, A. J., Ruge, F., Lane, J., Morris, C. A., Jiang, W. G. and Harding, K. G. 2019. Development and validation of a gene expression test to identify hard-to-heal chronic venous leg ulcers. British Journal of Surgery 106(8), pp. 1035-1042. (10.1002/bjs.11161)
• Zhong, W. et al. 2019. Effect of younger age on survival outcomes in T1N0M0 breast cancer: A propensity score matching analysis. Journal of Surgical Oncology 119(8), pp. 1039-1046. (10.1002/jso.25457)

2018

• Collins, R., Morgan, L., Owen, S., Ruge, F., Jiang, W. and Sanders, A. 2018. Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis. International Journal of Cancer 143(10), pp. 2537-2550. (10.1002/ijc.31786)
• Owen, S., Zabkiewicz, C., Ye, L., Sanders, A., Gong, C. and Jiang, W. 2018. Key factors in breast cancer dissemination and establishment at the bone: past, present and future perspectives. In: Song, E. and Hu, H. eds. Translational Research in Breast Cancer:Biomarker Diagnosis, Targeted Therapies and Approaches to Precision., Vol. 1026. Advances in Experimental Medicine and Biology Singapore: Kluwer, pp. 197-216., (10.1007/978-981-10-6020-5_9)

2017

• Laprevotte, E. et al. 2017. The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway. Oncotarget 8, pp. 113360-113372. (10.18632/oncotarget.23008)
• Uhercik, M., Sanders, A. J., Owen, S., Davies, E. L., Sharma, A. K., Jiang, W. G. and Mokbel, K. 2017. Clinical significance of PD1 and PDL1 in human breast cancer. Anticancer Research 37(8), pp. 4249-4254. (10.21873/anticanres.11817)
• Sobkowicz, A. D., Sanders, A. J., Mason, M. D. and Jiang, W. G. 2017. Potential implication of Paxillin in cancer establishment within the bone environment. Anticancer Research 37(8), pp. 4255-4268. (10.21873/anticanres.11818)
• Yu, Z., Sanders, A. J., Owen, S., Cheng, S., Yang, X. and Jiang, W. G. 2017. Expression of osteoprotegrin is enhanced in lung cancer tissues and promotes aggressive cellular traits in H3122 lung cancer cells. Anticancer Research 37(8), pp. 4277-4283. (10.21873/anticanres.11820)
• Lopes-Bastos, B. et al. 2017. Association of breast carcinoma growth with a non-canonical axis of IFNγ/IDO1/TSP1. Oncotarget (10.18632/oncotarget.18781)
• Rangaraj, A., Ye, L., Sanders, A., Price, P. E., Harding, K. G. and Jiang, W. G. 2017. Molecular and cellular impact of Psoriasin (S100A7) on the healing of human wounds. Experimental and Therapeutic Medicine 13(5), pp. 2151-2160. (10.3892/etm.2017.4275)
• Liu, Z., Sanders, A. J., Liang, G., Song, E., Jiang, W. G. and Gong, C. 2017. Hey factors at the crossroad of tumorigenesis and clinical therapeutic modulation of Hey for anticancer treatment. Molecular Cancer Therapeutics 16(5), pp. 775-786. (10.1158/1535-7163.MCT-16-0576)
• Feng, Y., Sanders, A. J., Morgan, L. D., Owen, S., Ruge, F., Harding, K. G. and Jiang, W. G. 2017. In vitro significance of SOCS-3 and SOCS-4 and potential mechanistic links to wound healing. Scientific Reports 7(1), article number: 6715. (10.1038/s41598-017-06886-6)

2016

• Feng, Y., Sanders, A., Ruge, F., Morris, C., Harding, K. and Jiang, W. 2016. Expression of the SOCS family in human chronic wound tissues: Potential implications for SOCS in chronic wound healing. International Journal of Molecular Medicine 38(5), pp. 1349-1358. (10.3892/ijmm.2016.2733)
• Jones, A. M., Griffiths, J. L., Sanders, A. J., Owen, S., Ruge, F., Harding, K. and Jiang, W. G. 2016. The clinical significance and impact of interleukin 15 on keratinocyte cell growth and migration. International Journal of Molecular Medicine 38, pp. 679-686. (10.3892/ijmm.2016.2687)
• Bartlett, A., Sanders, A. J., Ruge, F., Harding, K. G. and Jiang, W. G. 2016. Potential implications of interleukin-7 in chronic wound healing. Experimental and Therapeutic Medicine 12(1), pp. 33-40. (10.3892/etm.2016.3263)
• Owen, S., Sanders, A. J., Mason, M. D. and Jiang, W. G. 2016. Importance of osteoprotegrin and receptor activator of nuclear factor kB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. International Journal of Oncology 48(3), pp. 919-928. (10.3892/ijo.2016.3339)
• Owen, S., Sanders, A. J., Mason, M. D. and Jiang, W. G. 2016. Targeting of Receptor Activator of Nuclear Kappa B (RANK) in PC-3 cells increases cell proliferation and matrix adhesion in vitro.. Anticancer Research 36(3), pp. 1127-1134.
• Jia, J., Ke, J., Ji, J., Hao, C., Ye, L., Sanders, A. J. and Jiang, W. 2016. IL24 and its receptors regulate growth and migration of pancreatic cancer cells and are potential biomarkers for IL24 molecular therapy. Anticancer Research 36(3), pp. 1153-1163.
• Weeks, H., Sanders, A., Kynaston, H. and Jiang, W. 2016. The association between WAVE1 and -3 and the ARP2/3 complex in PC 3 cells. Anticancer Research 36(3), pp. 1135-1142.
• Jia, W., Feng, Y., Sanders, A. J., Davies, E. L. and Jiang, W. G. 2016. Phosphoinositide-3-kinase enhancers, PIKEs: their biological functions and roles in cancer. Anticancer Research 36(3), pp. 1103-1109.
• Feng, Y., Sanders, A., Morgan, L., Harding, K. and Jiang, W. 2016. Potential roles of suppressor of cytokine signaling in wound healing. Regenerative Medicine 11(2), pp. 193-209. (10.2217/rme.16.4)
• Sanders, A. J., Owen, S., Topley, N., Kift-Morgan, A. P. and Jiang, W. G. 2016. Implication of IL-7 in mesothelial paracellular resistance, migration and interaction with colorectal cancer cells [Abstract]. European Journal of Cancer 51(S3), pp. S23-S24., article number: 182. (10.1016/S0959-8049(16)30079-X)
• Jiang, W. G. et al. 2016. Effects of YangZheng XiaoJi on the migration and growth of lung cancer cells, by targeting the Hepatocyte Growth Factor Receptor-Epidermal Growth Factor Receptor (HGFR-EGFR) transactivation [Abstract]. European Journal of Cancer 51(S3), pp. S642-S642., article number: 3117. (10.1016/S0959-8049(16)31758-0)
• Jia, W. et al. 2016. Expression of the Epithelial-Mesenchymal-Transition (EMT) markers, Twist, Slug, Snail, E- and N-cadherins and the association with clinical and pathological features of human pituitary adenomas [Abstract]. European Journal of Cancer 51(S3), pp. S592-S593., article number: 2925. (10.1016/S0959-8049(15)30055-1)
• Wang, S., Ye, L., Sanders, A. J., Ruge, F., Harding, K. G. and Jiang, W. G. 2016. Tumour endothelial marker-8 in wound healing and its impact on the proliferation and migration of keratinocytes. International Journal of Molecular Medicine 37(2), pp. 293-298. (10.3892/ijmm.2015.2434)

2015

• Collins, R. J., Jiang, W. G., Hargest, R., Mason, M. D. and Sanders, A. J. 2015. EPLIN: a fundamental actin regulator in cancer metastasis?. Cancer and Metastasis Reviews 34(4), pp. 753-764. (10.1007/s10555-015-9595-8)
• Block, K. I. et al. 2015. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Seminars in Cancer Biology 35, pp. S276-S304. (10.1016/j.semcancer.2015.09.007)
• Jiang, W. G. et al. 2015. Tissue invasion and metastasis: molecular, biological and clinical perspectives. Seminars in Cancer Biology 35, pp. S244-S275. (10.1016/j.semcancer.2015.03.008)
• Tan, Y., Sanders, A. J., Xie, Y., Martin, T. A., Owen, S., Ruge, F. and Jiang, W. G. 2015. Interleukin-24 (IL-24) expression and biological impact on HECV endothelial cells.. Cancer Genomics and Proteomics 12(5), pp. 243-250.
• Owen, S. et al. 2015. An investigation of Amphiphysin II transcript expression in pituitary adenomas [Abstract]. European Journal of Cancer 51(S3), pp. S580-S580., article number: 2806. (10.1016/S0959-8049(15)30053-8)
• Ye, L. et al. 2015. Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis (review). Oncology Letters 10(3), pp. 1240-1250. (10.3892/ol.2015.3459)
• Jiang, W. G. et al. 2015. 3117 Effects of YangZheng XiaoJi on the migration and growth of lung cancer cells, by targeting the Hepatocyte Growth Factor Receptor-Epidermal Growth Factor Receptor (HGFR-EGFR) transactivation. European Journal of Cancer 51(Supp 1), pp. S642. (10.1016/S0959-8049(16)31758-0)
• Jiang, W. G. et al. 2015. YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells. Journal of Translational Medicine 13, article number: 280. (10.1186/s12967-015-0639-1)
• Jia, W. et al. 2015. Association of mta-1 expression in pituitary tumours with bone invasion. Anticancer Research 35(7), pp. 4360.
• Wazir, U. et al. 2015. Effects of the knockdown of death-associated protein 3 expression on cell adhesion, growth and migration in breast cancer cells. Oncology Reports 33(5), pp. 2575-2582. (10.3892/or.2015.3825)
• Jia, W. et al. 2015. Expression of metastasis-associated gene-1 is associated with bone invasion and tumor stage in human pituitary adenomas. Cancer Genomics and Proteomics 12(3), pp. 113-118.
• Wazir, U. et al. 2015. Effect of the knockdown of death-associated protein 1 expression on cell adhesion, growth and migration in breast cancer cells. Oncology Reports 33(3), pp. 1450-1458. (10.3892/or.2014.3686)
• Jiang, W. et al. 2015. Expression of Sonic Hedgehog (SHH) in human lung cancer and the impact of YangZheng XiaoJi on SHH-mediated biological function of lung cancer cells and tumor growth.. Anticancer Research 35(3), pp. 1321-1331.
• Glasbey, J., Sanders, A. J., Bosanquet, D. C., Ruge, F., Harding, K. G. and Jiang, W. 2015. Expression of hepatocyte growth factor-like protein in human wound tissue and its biological functionality in human keratinocytes. Biomedicines 3(1), pp. 110-123. (10.3390/biomedicines3010110)
• Webber, J. P. et al. 2015. Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. Oncogene 34(3), pp. 290-302. (10.1038/onc.2013.560)
• Jia, W., Zhu, J., Martin, T. A., A, J., Sanders, A. J. and Jiang, W. 2015. Epithelial-mesenchymal transition (EMT) markers in human pituitary adenomas indicate a clinical course. Anticancer Research 35(5), pp. 2635-2643.

2014

• Jones, A. M., Sanders, A. J., Ruge, F., Harding, K. G. and Jiang, W. G. 2014. The expression of interleukin 17c (IL-17c) in chronic wounds and its effect on an in vitro model of keratinocyte cell migration [Abstract]. Wound Repair and Regeneration 22(5), pp. A85-A85. (10.1111/wrr.12218)
• Jiang, W. G., Sanders, A. J., Cox, E. D., Bosanquet, D. C., Ruge, F., Lane, J. and Harding, K. G. 2014. A gene expression signature that predicted the clinical outcome of chronic wounds [Abstract]. Wound Repair and Regeneration 22(5), pp. A84-A84. (10.1111/wrr.12218)
• Ye, L., Sun, P., Sanders, A. J., Martin, T. A., Lane, J., Mason, M. D. and Jiang, W. G. 2014. Therapeutic potential of capillary morphogenesis gene 2 extracellular vWA domain in tumour-related angiogenesis. International Journal of Oncology 45(4), pp. 1565-1573. (10.3892/ijo.2014.2533)
• Sanders, A. J., Ye, L., Li, J., Mason, M. D. and Jiang, W. G. 2014. Tumour angiogenesis and repulsive guidance molecule b: A role in HGF- and BMP-7-mediated angiogenesis. International Journal of Oncology 45(3), pp. 1304-1312. (10.3892/ijo.2014.2508)
• Ye, L., Sanders, A. J., Sun, P., Mason, M. D. and Jiang, W. G. 2014. Capillary morphogenesis gene 2 regulates adhesion and invasiveness of prostate cancer cells. Onology Letters 7(6), pp. 2149-2153. (10.3892/ol.2014.2038)
• Jones, A. M., Sanders, A. J., Ruge, F., Harding, K. G. and Jiang, W. G. 2014. The effect of interleukin-17B on an in vitro model of human keratinocyte cell migration during wound healing. British Journal of Surgery 101(s4), pp. 28., article number: O97. (10.1002/bjs.9508)
• Jones, A. M., Sanders, A. J., Griffiths, J. L., Ruge, F., Harding, K. G. and Jiang, W. G. 2014. The effect of interleukin 15 on an in vitro model of human keratinocyte cell migration in wound healing. British Journal of Surgery 101(S4), pp. 25., article number: O86. (10.1002/bjs.9508)

2013

• Ye, L., Sun, P., Martin, T. A., Sanders, A. J., Mason, M. D. and Jiang, W. G. 2013. Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells. Urologic Oncology: Seminars and Original Investigations 31(8), pp. 1576-1583. (10.1016/j.urolonc.2012.05.006)
• Jiang, W. G., Ye, L., Sanders, A. J., Ruge, F., Kynaston, H., Ablin, R. J. and Mason, M. D. 2013. Prostate transglutaminase (TGase-4, TGaseP) enhances the adhesion of prostate cancer cells to extracellular matrix, the potential role of TGase-core domain. Journal of Translational Medicine 11, article number: 269. (10.1186/1479-5876-11-269)
• Sobkowicz, A., Sanders, A. J., Ruge, F. and Jiang, W. G. 2013. Expression profile of amphyphysin I in normal and breast cancer specimens. European Journal of Cancer 49, pp. S198-S198.
• Owen, S., Sanders, A. J., Ye, L., Mason, M. D. and Jiang, W. G. 2013. Osteomodulin expression profile in human breast cancer [Abstract]. European Journal of Cancer 49, pp. S197-S197. (10.1016/S0959-8049(13)70061-3)
• Sobkowicz, A., Sanders, A. J., Mason, M. D. and Jiang, W. G. 2013. Paxillin in the prostate cancer cell models [Abstract]. European Journal of Cancer 49, pp. S686-S687.
• Sanders, A. J., Sobkowicz, A., Owen, S., Ye, L., Mason, M. D. and Jiang, W. G. 2013. A role for activated leukocyte cell adhesion molecule (ALCAM) in the growth and matrix adhesion of prostate cancer cells [Abstract]. European Journal of Cancer 49, pp. S685-S685.
• Jia, W., Sanders, A. and Jiang, W. 2013. Evidence of cathepsin K (CTSK) in the aggressive development and invasion of pituitary adenomas. European Journal of Cancer 49(Supp 2), pp. S217.
• Liu, C. et al. 2013. Molecular angiogenic events of a two-herb wound healing formula involving MAPK and Akt signaling pathways in human vascular endothelial cells. Wound Repair and Regeneration 21(4), pp. 579-587. (10.1111/wrr.12055)
• Xie, C. et al. 2013. CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer. Oncogene 32(18), pp. 2282-2291. (10.1038/onc.2012.251)
• Webb, S. L., Sanders, A. J., Mason, M. D. and Jiang, W. G. 2013. Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo. Molecular and Cellular Biochemistry 375(1-2), pp. 207-217. (10.1007/s11010-012-1544-z)
• Owen, S., Ye, L., Sanders, A., Mason, M. and Jiang, W. 2013. Expression profile of receptor activator of nuclear-kappa B (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. Anticancer Research 33(1), pp. 199-206.
• Martin, T. A., Ye, L., Sanders, A. J., Lane, J. and Jiang, W. G. 2013. Cancer invasion and metastasis: molecular and cellular perspective. In: Jandial, R. ed. Metastatic Cancer Clinical and Biological Perspectives. Austin, TX: Landes Bioscience, pp. 135-168.
• Frewer, K., Sanders, A. J., Owen, S., Frewer, N., Hargest, R. and Jiang, W. G. 2013. A role for WISP2 in colorectal cancer cell invasion and motility. Cancer Genomics and Proteomics 10(4), pp. 187-196.
• Jia, W., Sanders, A. J., Jia, G., Liu, X., Lu, R. and Jiang, W. G. 2013. Expression of the mTOR pathway regulators in human pituitary adenomas indicate the clinical course. Anticancer Research 33, pp. 3123-3131.
• Yin, Y., Sanders, A. J. and Jiang, W. G. 2013. The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance. Anticancer Research 33, pp. 1499-1509.
• Ge, Z., Sanders, A. J., Ye, L., Mansel, R. E. and Jiang, W. G. 2013. Expression of death receptor-3 in human breast cancer and its functional effects on breast cancer cells in vitro. Oncology Reports 29, pp. 1356-1364. (10.3892/or.2013.2259)

2012

• Bosanquet, D. C., Harding, K. G., Ruge, F., Sanders, A. J. and Jiang, W. G. 2012. Expression of IL-24 and IL-24 receptors in human wound tissues and the biological implications of IL-24 on keratinocytes. Wound Repair and Regeneration 20(6), pp. 896-903. (10.1111/j.1524-475X.2012.00840.x)
• Webb, S. L., Sanders, A. J., Mason, M. and Jiang, W. 2012. The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin. Oncology Reports 28(4), pp. 1491-1497. (10.3892/or.2012.1945)
• Saravolac, V., Sanders, A. J., Bosanquet, D. C., Jiang, W. G. and Harding, K. G. 2012. Potential role of focal adhesion kinase (FAK) in epithelial protein lost in neoplasm (EPLIN)- regulated migration of hacat cells [Abstract]. Wound Repair and Regeneration 20(5), pp. A110. (10.1111/j.1524-475X.2012.00834.x)
• Saravolac, V., Sanders, A. J., Bosanquet, D. C., Jiang, W. G. and Harding, K. G. 2012. Relationship of extracellular signal-regulated kinase (ERK) and epithelial protein lost in meoplasm(EPLIN) in hacat cell migration [Abstract]. Wound Repair and Regeneration 20(5), pp. A110. (10.1111/j.1524-475X.2012.00834.x)
• Bosanquet, D. C., Ye, L., Saravolac, V., Sanders, A. J., Rangaraj, A., Harding, K. G. and Jiang, W. G. 2012. Ehm2 promotes wounds healing; the involvement of FAK and NWasp [Abstract]. Wound Repair and Regeneration 20(5), pp. A86. (10.1111/j.1524-475X.2012.00834.x)
• Li, J., Ye, L., Sanders, A. J. and Jiang, W. G. 2012. Repulsive guidance molecule B (RGMB) plays negative roles in breast cancer by coordinating BMP signaling. Journal of Cellular Biochemistry 113(7), pp. 2523-2531. (10.1002/jcb.24128)
• Baig, R. . M., Sanders, A. J., Kayani, M. A. and Jiang, W. G. 2012. Association of differentiation-related gene-1 (DRG1) with breast cancer survival and in vitro impact of DRG1 suppression. Cancers 4(3), pp. 658-672. (10.3390/cancers4030658)
• Liu, Y., Sanders, A. J., Zhang, L. and Jiang, W. G. 2012. EPLIN-α expression in human oesophageal cancer and its impact on cellular aggressiveness and clinical outcome. Anticancer Research 32(4), pp. 1283-1289.
• Jiang, W. G., Sanders, A. J., Ruge, F. and Harding, K. G. 2012. Influence of interleukin-8 (IL-8) and IL-8 receptors on the migration of human keratinocytes, the role of PLC-γ and potential clinical implications. Experimental and Therapeutic Medicine 3(2), pp. 231-236. (10.3892/etm.2011.402)
• Jiang, W., Sanders, A., Ruge, F. and Harding, K. 2012. Influence of interleukin-8 (IL-8) and IL-8 receptors on the migration of human keratinocytes, the role of PLC-gamma and potential clinical implications. Experimental and Therapeutic Medicine 3(2), pp. 231-236. (10.3892/etm.2011.402)
• Liu, Y., Sanders, A. J., Zhang, L. and Jiang, W. G. 2012. Expression profile of epithelial protein lost in neoplasm-alpha (EPLIN-alpha) in human pulmonary cancer and its impact on SKMES-1 cells in vitro. Journal of Cancer Therapy 3, pp. 452-459. (10.4236/jct.2012.324058)

2011

• Sanders, A. J., Martin, T. A., Ye, L., Mason, M. D. and Jiang, W. G. 2011. EPLIN is a negative regulator of prostate cancer growth and invasion. The Journal of Urology 186(1), pp. 295-301. (10.1016/j.juro.2011.03.038)
• Yuan, Z., Sanders, A. J., Ye, L., Wang, Y. and Jiang, W. G. 2011. Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9. Oncology Reports 26(1), pp. 237-245. (10.3892/or.2011.1271)
• Bosanquet, D. C., Ye, L., Saravolac, V., Sanders, A. J., Rangaraj, A., Harding, K. G. and Jiang, W. G. 2011. Keratinocyte migration, wound healing and the role of the novel protein EHM2 [Abstract]. Wound Repair and Regeneration 19(2), pp. A14. (10.1111/j.1524-475X.2010.00670.x)
• Bosanquet, D. C., Ye, L., Saravolac, V., Sanders, A. J., Rangaraj, A., Harding, K. G. and Jiang, W. G. 2011. The role of HuR in keratinocyte migration and wound healing [Abstract]. Wound Repair and Regeneration 19(2), pp. A14. (10.1111/j.1524-475X.2010.00670.x)
• Webb, S. L., Sanders, A. J., Mason, M. D. and Jiang, W. G. 2011. Type II transmembrane serine protease (TTSP) deregulation in cancer. Frontiers in Bioscience 16, pp. 539-552.
• Yuan, Z., Sanders, A. J., Ye, L., Wang, Y. and Jiang, W. G. 2011. Prognostic value of the human antigen R (HuR) in human breast cancer: high level predicts a favourable prognosis. Anticancer Research 31(1), pp. 303-310.
• Bosanquet, D. C., Sanders, A. J., Parr, C., Harding, K. G. and Jiang, W. G. 2011. The role of metastasis suppressor 1 (MTSS1) in angiogenesis [Abstract]. Wound Repair and Regeneration 19(2), pp. A14. (10.1111/j.1524-475X.2010.00670.x)
• Jiang, W. G. and Sanders, A. J. 2011. Hepatocyte growth factor is a potential lymphangiogenic factor: clinical implications. Current Signal Transduction Therapy 6(2), pp. 168-172. (10.2174/157436211795659900)
• Sanders, A. J., Jiang, D. G., Jiang, W. G., Harding, K. G. and Patel, G. K. 2011. Activated leukocyte cell adhesion molecule impacts on clinical wound healing and inhibits HaCaT migration. International Wound Journal 8(5), pp. 500-507. (10.1111/j.1742-481X.2011.00823.x)
• Ge, Z., Sanders, A. J., Ye, L. and Jiang, W. G. 2011. Aberrant expression and function of death receptor-3 and death decoy receptor-3 in human cancer. Experimental and Therapeutic Medicine 2(2), pp. 167-172. (10.3892/etm.2011.206)
• Ge, Z., Sanders, A. J., Ye, L., Wang, Y. and Jiang, W. G. 2011. Expression of death decoy receptor-3 (DcR3) in human breast cancer and its functional effects on breast cancer cells in vitro. Journal of Experimental Therapeautics and Oncology 9, pp. 109-118. (10.3892/or.2013.2259)

2010

• Sanders, A. J., Ye, L., Mason, M. D. and Jiang, W. G. 2010. The impact of EPLINα (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis. Angiogenesis 13(4), pp. 317-326. (10.1007/s10456-010-9188-7)
• Davies, S., Davies, M. L., Sanders, A. J., Parr, C., Torkington, J. and Jiang, W. G. 2010. Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications. International Journal of Oncology 36(5), pp. 1129-1136. (10.3892/ijo_00000595)
• Davies, M. L., Parr, C., Sanders, A. J., Fodstad, O. and Jiang, W. G. 2010. The transcript expression and protein distribution pattern in human colorectal carcinoma reveal a pivotal role of COM-1/p8 as a tumour suppressor. Cancer Genomics and Proteomics 7(2), pp. 75-80.
• Zhang, N., Sanders, A. J., Ye, L., Kynaston, H. and Jiang, W. 2010. Expression of vascular endothelial growth inhibitor (VEGI) in human urothelial cancer of the bladder and its effects on the adhesion and migration of bladder cancer cells in vitro. Anticancer Research 30(1), pp. 87-95.
• Parr, C., Sanders, A. J. and Jiang, W. G. 2010. Hepatocyte growth factor activation inhibitors - therapeutic potential in cancer. Anti-Cancer Agents in Medicinal Chemistry 10(1), pp. 47-57.
• Sanders, A. J., Webb, S. L., Parr, C., Mason, M. D. and Jiang, W. G. 2010. The type II transmembrane serine protease, matriptase-2: possible links to cancer ?. Anti-Cancer Agents in Medicinal Chemistry 10(1), pp. 64-69.
• Minhas, U., Sanders, A. J., Patel, G. K., Harding, K. G. and Jiang, W. G. 2010. Activated leukocyte cell adhesion molecule (ALCAM) - biological impact on vascular endothelial cells [Abstract]. Wound Repair and Regeneration 18(6), pp. A89. (10.1111/j.1524-475X.2010.00633.x)
• Jiang, W. G., Sanders, A. J. and Harding, K. G. 2010. Expression of vegi, vascular endothelial growth inhibitor, and its impact on cellular functions of keratinocytes [Abstract]. Wound Repair and Regeneration 18(6), pp. A84. (10.1111/j.1524-475X.2010.00633.x)
• Yuan, Z., Sanders, A. J., Ye, L. and Jiang, W. G. 2010. HuR, a key post-transcriptional regulator, and its implication in progression of breast cancer. Histology and Histopathology 25(10), pp. 1331-1340.
• Fernando, H. S., Sanders, A. J., Kynaston, H. and Jiang, W. G. 2010. WAVE3 is associated with invasiveness in prostate cancer cells. Urologic Oncology: Seminars and Original Investigations 28(3), pp. 320-327. (10.1016/j.urolonc.2008.12.022)

2009

• Zhang, N., Sanders, A. J., Ye, L., Kynaston, H. and Jiang, W. G. 2009. Vascular endothelial growth inhibitor, expression in human prostate cancer tissue and the impact on adhesion and migration of prostate cancer cells in vitro. International Journal of Oncology 35(6), pp. 1473-1480. (10.3892/ijo_00000466)
• Malik, F. A., Sanders, A. J., Kayani, M. A. and Jiang, W. G. 2009. Effect of expressional alteration of KAI1 on breast cancer cell growth, adhesion, migration and invasion. Cancer Genomics and Proteomics 6(4), pp. 205-213.
• Zhang, N., Sanders, A. J., Ye, L. and Jiang, W. G. 2009. Vascular endothelial growth inhibitor in human cancer (Review). International Journal of Molecular Medicine 24(1), pp. 3-8. (10.3892/ijmm_00000198)
• Malik, F. A., Sanders, A. J., Douglas-Jones, A. G., Mansel, R. E. and Jiang, W. G. 2009. Transcriptional and translational modulation of KAI1 expression in ductal carcinoma of the breast and the prognostic significance. International Journal of Molecular Medicine 23(2), pp. 273-278. (10.3892/ijmm_00000127)
• Malik, F. A., Sanders, A. J. and Jiang, W. G. 2009. KAI-1/CD82, The molecule and clinical implication in cancer and cancer metastasis. Histology and Histopathology 24(4), pp. 519-530.

2008

• Sanders, A. J., Parr, C., Martin, T. A., Lane, J., Mason, M. D. and Jiang, W. G. 2008. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation. Journal of Cellular Physiology 216(3), pp. 780-789. (10.1002/jcp.21460)
• Fernando, H., Sanders, A. J., Jenkins, S., Kynaston, H. and Jiang, W. G. 2008. Wave 3 (Wasp Verprolin-Homologous Protein) 3 is involved in the invasiveness of PC-3 cells [Abstract]. European Urology Supplements 7(3), pp. 173. (10.1016/S1569-9056(08)60406-6)
• Fernando, H. S., Sanders, A. J., Kynaston, H. and Jiang, W. G. 2008. WAVE1 is Associated with Invasiveness and Growth of Prostate Cancer Cells. The Journal of Urology 180(4), pp. 1515-1521. (10.1016/j.juro.2008.06.004)
• Ye, L., Lewis-Russell, J. M., Sanders, A. J., Kynaston, H. G. and Jiang, W. G. 2008. HGF/SF up-regulates the expression of bone morphogenetic protein 7 in prostate cancer cells. Urologic Oncology: Seminars and Original Investigations 26(2), pp. 190-197. (10.1016/j.urolonc.2007.03.027)

2007

• Sanders, A. J., Parr, C., Mason, M. D. and Jiang, W. G. 2007. Suppression of hepatocyte growth factor activator inhibitor-1 leads to a more aggressive phenotype of prostate cancer cells in vitro. International Journal of Molecular Medicine 20(4), pp. 613-619.
• Parr, C. et al. 2007. Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients. Clinical Cancer Research 13(12), pp. 3568-3576. (10.1158/1078-0432.CCR-06-2357)

2006

• Sanders, A. J., Parr, C., Davies, G., Martin, T. A., Lane, J., Mason, M. D. and Jiang, W. G. 2006. Genetic reduction of matriptase-1 expressionj is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeautics and Oncology 6(1), pp. 39-48.
• Sanders, A. J., Parr, C., Davies, G., Martin, T. A., Lane, J., Mason, M. D. and Jiang, W. G. 2006. Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeutics and Oncology 6(1), pp. 39-48.